Protagonist Therapeutics, Inc. (PTGX)

94.40 +2.14 (+2.33%) USD  |  NASDAQ  |  Dec 12, 12:35
More

Protagonist Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade